FOR IMMEDIATE RELEASE Contact: Wendi ChasonMount Sinai Press Office(212) 241-9200[email protected]
Mount Sinai Physicians First in United States to Perform Cardiac Catheter Ablation Procedure Using Innovative Device
Newswise — NEW YORK, NY (October 4, 2016) – Mount Sinai physicians have become the first in the country to perform cardiac ablation procedures using a new, state-of-the-art catheter. Vivek Reddy, MD, The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology and his colleagues, Srinivas Dukkipati, MD, Director of the Electrophysiology Laboratory at The Mount Sinai Hospital, and Subbarao Choudry, MD, Assistant Clinical Professor, Cardiology, performed the first and second procedures in the United States with the IntellaNav OI catheter on September 29 and 30.
The IntellaNav OI, made by Boston Scientific, has both internal and external tip cooling during ablation, now enhanced with IntellaNav magnetic tracking technology for increased accuracy, efficiency and performance during catheter ablation procedures. Both patients had atypical atrial flutter rhythms that were successfully eliminated with the ablation procedures. Atrial flutter is an abnormal heart rhythm that occurs in the atria of the heart.
The newly FDA-approved IntellaNav OI catheter features magnetic sensors that track the location of the catheter while delivering radio-frequency energy into the heart muscle, creating heat to destroy a small area of the tissue responsible for the abnormal heart rhythm. The IntellaNav OI catheter provides cooling of the catheter tip to help prevent char and coagulum formation for additional safety and more effective treatment of the arrhythmia within ablation procedures.
"We are committed to offering the latest technologies to treat our patients, and are pleased to be one of the first institutions in the United States to offer the innovative IntellaNav OI,” said Dr. Reddy. “The catheter provides additional safety within ablation procedures and is an important addition to our full suite of services to diagnose and treat a variety of heart rhythm conditions.”
Mount Sinai is a pioneer in the diagnosis and treatment of patients with abnormal heart rhythms. Its electrophysiology department has been leading the development of new arrhythmia technologies since 1909, when one of its physicians became the first in the United States to use an electrocardiogram. Today, the Helmsley Center for Electrophysiology at Mount Sinai, directed by Dr. Reddy, provides the full spectrum of therapies, from procedures that implant devices for regulating heart rhythms (such as pacemakers) to procedures that use catheters for fixing the source of the abnormal heartbeat (called ablations).
In an effort to make ablations safer and more effective, the Center has been the first in the country to use several breakthrough technologies, including a visually guided laser balloon catheter in 2009 and the TactiCath force-sensing catheter in 2011, as well as a new generation of visually guided catheters in 2012. Dr. Reddy was the first physician in the world to use several new ablation techniques to treat atrial fibrillation, such as the cryoballoon catheter and robotic navigation. In addition, in 2014, Dr. Reddy implanted inside a patient's heart the first, innovative, miniature leadless pacemaker in the United States at The Mount Sinai Hospital.
Dr. Reddy is a consultant to Boston Scientific, the manufacturer of the IntellaNav OI.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.
The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the “Honor Roll” of best hospitals in America, ranked No. 15 nationally in the 2016-2017 “Best Hospitals” issue of U.S. News & World Report. The Mount Sinai Hospital is also ranked as one of the nation’s top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai West are ranked regionally. Mount Sinai’s Kravis Children’s Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in "Best Children's Hospitals."
For more information, visit http://www.mountsinai.org/ or find Mount Sinai on Facebook, Twitter and YouTube.
RSS